{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:16:37Z","timestamp":1788426997050,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Institutes for Medical Research Development","award":["983005"],"award-info":[{"award-number":["983005"]}]},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"crossref","award":["24350"],"award-info":[{"award-number":["24350"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00653-7","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:41:07Z","timestamp":1788424867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of acquired capecitabine resistance in MKN-45 gastric cancer cells reveals preserved apoptotic sensitivity"],"prefix":"10.1007","volume":"34","author":[{"given":"Habibeh Sadat","family":"Mohseni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohreh","family":"Tavajohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Kebriaeezadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Ghahremani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5476-8010","authenticated-orcid":false,"given":"Seyed Nasser","family":"Ostad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"653_CR1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28:1187\u2013203. https:\/\/doi.org\/10.3748\/wjg.v28.i12.1187.","journal-title":"World J Gastroenterol"},{"key":"653_CR2","doi-asserted-by":"publisher","unstructured":"Su P, Jiang L, Zhang Y, et al. Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5\/PI3K\/AKT\/mTOR pathway in gastric cancer. Cancer Cell Int. 2022;22. https:\/\/doi.org\/10.1186\/s12935-022-02717-5.","DOI":"10.1186\/s12935-022-02717-5"},{"key":"653_CR3","doi-asserted-by":"publisher","unstructured":"Liu J, Yuan Q, Guo H, Guan H, Hong Z, Shang D. Deciphering drug resistance in gastric cancer: potential mechanisms and future perspectives. Biomed Pharmacother. 2024;173:116310. https:\/\/doi.org\/10.1016\/j.biopha.2024.116310.","DOI":"10.1016\/j.biopha.2024.116310"},{"key":"653_CR4","doi-asserted-by":"crossref","unstructured":"Marin JJ, Al-Abdulla R, Lozano E, Briz O, et al. Mechanisms of resistance to chemotherapy in gastric cancer. 2016.","DOI":"10.2174\/1871520615666150803125121"},{"key":"653_CR5","first-page":"102","volume":"2","author":"AM Vanave","year":"2024","unstructured":"Vanave AM, Chougle N, Kamble J, Salokhe P. Capecitabine: A Promising Anticancer Drug. J Pharma Insights Res. 2024;2:102\u20137.","journal-title":"J Pharma Insights Res"},{"key":"653_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3892\/or.2023.8612","volume":"50","author":"SM Alzahrani","year":"2023","unstructured":"Alzahrani SM, Al Doghaither HA, Al\u2013Ghafari AB, Pushparaj PN. 5\u2013Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review). Oncol Rep. 2023;50:175. https:\/\/doi.org\/10.3892\/or.2023.8612.","journal-title":"Oncol Rep"},{"key":"653_CR7","doi-asserted-by":"publisher","first-page":"1178489","DOI":"10.3389\/fphar.2023.1178489","volume":"14","author":"N Danisik","year":"2023","unstructured":"Danisik N, Yilmaz KC, Acar A. Identification of collateral sensitivity and evolutionary landscape of chemotherapy-induced drug resistance using cellular barcoding technology. Front Pharmacol. 2023;14:1178489.","journal-title":"Front Pharmacol"},{"key":"653_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.22088\/ijmcm.bums.12.4.361","volume":"12","author":"Z Mahdian","year":"2023","unstructured":"Mahdian Z, Pouramir M, Akrami H, Zabihi E. Evaluation of Drug Resistance in the Tamoxifen-treated MKN-45 Gastric Cancer Cell Line via the Epithelial-mesenchymal Transition Signaling Pathway. Int J Mol Cell Med. 2023;12:361\u201371. https:\/\/doi.org\/10.22088\/ijmcm.bums.12.4.361.","journal-title":"Int J Mol Cell Med"},{"key":"653_CR9","first-page":"1545","volume":"20","author":"Y Tsutani","year":"2008","unstructured":"Tsutani Y, Yoshida K, Sanada Y, et al. Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line. Oncol Rep. 2008;20:1545\u201351.","journal-title":"Oncol Rep"},{"key":"653_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/cancers17020281","volume":"17","author":"SA Okun","year":"2025","unstructured":"Okun SA, Lu D, Sew K, Subramaniam A, Lockwood WW. MET activation in lung cancer and response to targeted therapies. Cancers. 2025;17:281.","journal-title":"Cancers"},{"key":"653_CR11","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1007\/s00210-024-03145-0","volume":"397","author":"K Zehra","year":"2024","unstructured":"Zehra K, Banu A, Can E, H\u00fclya C. Fisetin and\/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines. Naunyn Schmiedebergs Arch Pharmacol. 2024;397:7913\u201326.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"653_CR12","doi-asserted-by":"publisher","unstructured":"Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol Int. 2000;50. https:\/\/doi.org\/10.1046\/j.1440-1827.2000.01117.x.","DOI":"10.1046\/j.1440-1827.2000.01117.x"},{"key":"653_CR13","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1158\/0008-5472.CAN-14-2743","volume":"75","author":"A Shen","year":"2015","unstructured":"Shen A, Wang L, Huang M, et al. c-Myc alterations confer therapeutic response and acquired resistance to c-Met inhibitors in MET-addicted cancers. Cancer Res. 2015;75:4548\u201359.","journal-title":"Cancer Res"},{"key":"653_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12013-020-00937-y","volume":"78","author":"S Aghmasheh","year":"2020","unstructured":"Aghmasheh S, Ostad SN, Abedi A. Pharmacological Properties of Pt (II) and Pt (IV) Complexes with 2, 2\u2032-Dipyridylamine; the Comparative In Vitro Thereof. Cell Biochem Biophys. 2020;78:521\u20139.","journal-title":"Cell Biochem Biophys"},{"key":"653_CR15","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.procbio.2020.01.033","volume":"114","author":"F Pouremamali","year":"2022","unstructured":"Pouremamali F, Jeddi F, Samadi N. Nrf2-ME-1 axis is associated with 5-FU resistance in gastric cancer cell line. Process Biochem. 2022;114:174\u201384. https:\/\/doi.org\/10.1016\/j.procbio.2020.01.033.","journal-title":"Process Biochem"},{"key":"653_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-016-0302-1","volume":"9","author":"J Liu","year":"2016","unstructured":"Liu J, Pan C, Guo L, et al. A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K\/AKT signaling pathway. J Hematol Oncol. 2016;9:76. https:\/\/doi.org\/10.1186\/s13045-016-0302-1.","journal-title":"J Hematol Oncol"},{"key":"653_CR17","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.biopha.2018.07.055","volume":"106","author":"S Aliebrahimi","year":"2018","unstructured":"Aliebrahimi S, Kouhsari SM, Arab SS, Shadboorestan A, Ostad SN. Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors. Biomed Pharmacother. 2018;106:1527\u201336.","journal-title":"Biomed Pharmacother"},{"key":"653_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10555-019-09803-7","volume":"38","author":"A Biagioni","year":"2019","unstructured":"Biagioni A, Skalamera I, Peri S, et al. Update on gastric cancer treatments and gene therapies. Cancer Metastasis Rev. 2019;38:537\u201348. https:\/\/doi.org\/10.1007\/s10555-019-09803-7.","journal-title":"Cancer Metastasis Rev"},{"key":"653_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-024-01891-4","volume":"9","author":"J He","year":"2024","unstructured":"He J, Qiu Z, Fan J, Xie X, Sheng Q, Sui X. Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies. Signal Transduct Target Ther. 2024;9:209. https:\/\/doi.org\/10.1038\/s41392-024-01891-4.","journal-title":"Signal Transduct Target Ther"},{"key":"653_CR20","doi-asserted-by":"publisher","unstructured":"Ghoderao P, Kwiatkowska-Borowczyk E, Sahare S, Dams-Kozlowska H. Targeting drug-tolerant persister cancer cells: can nanomaterial-based strategies be helpful for Anti-DTP therapies? Pharmaceutics. 2025;17. https:\/\/doi.org\/10.3390\/pharmaceutics17111428.","DOI":"10.3390\/pharmaceutics17111428"},{"key":"653_CR21","doi-asserted-by":"publisher","first-page":"13438","DOI":"10.18632\/oncotarget.24412","volume":"9","author":"K Matsuoka","year":"2018","unstructured":"Matsuoka K, Nakagawa F, Kobunai T, Takechi T. Trifluridine\/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression. Oncotarget. 2018;9:13438\u201350. https:\/\/doi.org\/10.18632\/oncotarget.24412.","journal-title":"Oncotarget"},{"key":"653_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10120-018-0881-3","volume":"22","author":"R Mori","year":"2019","unstructured":"Mori R, Yoshida K, Futamura M, et al. The inhibition of thymidine phosphorylase can reverse acquired 5FU-resistance in gastric cancer cells. Gastric Cancer. 2019;22:497\u2013505. https:\/\/doi.org\/10.1007\/s10120-018-0881-3.","journal-title":"Gastric Cancer"},{"key":"653_CR23","doi-asserted-by":"publisher","first-page":"152392","DOI":"10.1016\/j.seminoncol.2025.152392","volume":"52","author":"A El-Sehrawy","year":"2025","unstructured":"El-Sehrawy A, Hsu CY, Alkhathami AG, et al. Metabolic reprogramming: The driving force behind cancer drug resistance. Semin Oncol. 2025;52:152392. https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152392.","journal-title":"Semin Oncol"},{"key":"653_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1023\/A:1006497231579","volume":"18","author":"H Ishitsuka","year":"2000","unstructured":"Ishitsuka H. Capecitabine: Preclinical Pharmacology Studies. Investig New Drugs. 2000;18:343\u201354. 10.1023\/A:1006497231579.","journal-title":"Investig New Drugs"},{"key":"653_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5487\/tr.2015.31.2.151","volume":"31","author":"AY Kim","year":"2015","unstructured":"Kim AY, Kwak JH, Je NK, Lee YH, Jung YS. Epithelial-mesenchymal Transition is Associated with Acquired Resistance to 5-Fluorocuracil in HT-29 Colon Cancer Cells. Toxicol Res. 2015;31:151\u20136. https:\/\/doi.org\/10.5487\/tr.2015.31.2.151.","journal-title":"Toxicol Res"},{"key":"653_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/molecules21070965","volume":"21","author":"B Du","year":"2016","unstructured":"Du B, Shim JS. Targeting Epithelial\u2013Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules. 2016;21:965.","journal-title":"Molecules"},{"key":"653_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12885-016-2058-y","volume":"16","author":"CH Park","year":"2016","unstructured":"Park CH, Cho SY, Ha JD, et al. Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells. BMC Cancer. 2016;16:35. https:\/\/doi.org\/10.1186\/s12885-016-2058-y.","journal-title":"BMC Cancer"},{"key":"653_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma SV, Lee DY, Li B, et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell. 2010;141:69\u201380. https:\/\/doi.org\/10.1016\/j.cell.2010.02.027.","journal-title":"Cell"},{"key":"653_CR29","doi-asserted-by":"publisher","first-page":"8521","DOI":"10.2147\/ott.S256274","volume":"13","author":"Z Sun","year":"2020","unstructured":"Sun Z, Luan S, Yao Y, et al. NHE1 Mediates 5-Fu Resistance in Gastric Cancer via STAT3 Signaling Pathway. Onco Targets Ther. 2020;13:8521\u201332. https:\/\/doi.org\/10.2147\/ott.S256274.","journal-title":"Onco Targets Ther"},{"key":"653_CR30","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/bjc.2017.32","volume":"116","author":"X Liang","year":"2017","unstructured":"Liang X, Shi H, Yang L, et al. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells. Br J Cancer. 2017;116:903\u201311. https:\/\/doi.org\/10.1038\/bjc.2017.32.","journal-title":"Br J Cancer"},{"key":"653_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1023\/a:1026476801463","volume":"2","author":"M Osaki","year":"1997","unstructured":"Osaki M, Tatebe S, Goto A, Hayashi H, Oshimura M, Ito H. 5-Fluorouracil (5-FU) induced apoptosis in gastric cancer cell lines: role of the p53 gene. Apoptosis. 1997;2:221\u20136. https:\/\/doi.org\/10.1023\/a:1026476801463.","journal-title":"Apoptosis"},{"key":"653_CR32","doi-asserted-by":"publisher","first-page":"e0309014","DOI":"10.1371\/journal.pone.0309014","volume":"19","author":"F-l Wang","year":"2024","unstructured":"Wang F-l, Chang X, Shi Y, et al. \u03b2-Ionone enhances the inhibitory effects of 5-fluorouracil on the proliferation of gastric adenocarcinoma cells by the GSK-3\u03b2 signaling pathway. PLoS ONE. 2024;19:e0309014. https:\/\/doi.org\/10.1371\/journal.pone.0309014.","journal-title":"PLoS ONE"},{"key":"653_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12885-026-15540-2","volume":"26","author":"J Li","year":"2026","unstructured":"Li J, Wang FL, Yang TT, et al. \u03b2-ionone synergizes with 5-Fluorouracil to inhibit gastric cancer progression through PAX6-mediated cell cycle arrest. BMC Cancer. 2026;26:192. https:\/\/doi.org\/10.1186\/s12885-026-15540-2.","journal-title":"BMC Cancer"},{"key":"653_CR34","doi-asserted-by":"publisher","first-page":"e2406276","DOI":"10.1002\/advs.202406276","volume":"11","author":"P Ding","year":"2024","unstructured":"Ding P, Wu J, Wu H, et al. Transcriptomics-Based Liquid Biopsy for Early Detection of Recurrence in Locally Advanced Gastric Cancer. Adv Sci (Weinh). 2024;11:e2406276. https:\/\/doi.org\/10.1002\/advs.202406276.","journal-title":"Adv Sci (Weinh)"},{"key":"653_CR35","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1186\/s12916-025-04393-4","volume":"23","author":"P Ding","year":"2025","unstructured":"Ding P, Chen S, Guo H, et al. Radiomics-based ensemble model predicts postoperative recurrence of gastric cancer. BMC Med. 2025;23:656. https:\/\/doi.org\/10.1186\/s12916-025-04393-4.","journal-title":"BMC Med"},{"key":"653_CR36","doi-asserted-by":"publisher","unstructured":"Ding P, Chen S, Guo H, et al. A deep learning-based digital biopsy for predicting early recurrence in gastric cancer. Nat Commun. 2026;17. https:\/\/doi.org\/10.1038\/s41467-026-71347-6.","DOI":"10.1038\/s41467-026-71347-6"},{"key":"653_CR37","doi-asserted-by":"publisher","first-page":"e2411490","DOI":"10.1002\/advs.202411490","volume":"12","author":"P Ding","year":"2025","unstructured":"Ding P, Yang J, Guo H, et al. Multimodal Artificial Intelligence-Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology-Positive Gastric Cancer. Adv Sci (Weinh). 2025;12:e2411490. https:\/\/doi.org\/10.1002\/advs.202411490.","journal-title":"Adv Sci (Weinh)"},{"key":"653_CR38","doi-asserted-by":"publisher","first-page":"e08190","DOI":"10.1002\/advs.202508190","volume":"12","author":"P Ding","year":"2025","unstructured":"Ding P, Yang J, Chen S, et al. Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer. Adv Sci (Weinh). 2025;12:e08190. https:\/\/doi.org\/10.1002\/advs.202508190.","journal-title":"Adv Sci (Weinh)"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00653-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:41:09Z","timestamp":1788424869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00653-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["653"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00653-7","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"27 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"One of the co-authors, Professor Abbas Kebriaeezadeh, is a member of the Editorial Board of DARU Journal of Pharmaceutical Sciences. He was not involved in the editorial assessment or peer review of this manuscript.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"68"}}